95 Results

People

  1. Zelenetz
    Zelenetz
  2. Palomba
    Palomba
  3. Noy
    Noy
  4. Intlekofer
    Intlekofer
  5. Hamlin
    Hamlin
  6. Horwitz
    Horwitz
  7. Kumar
    Kumar
  8. Moskowitz
    Moskowitz
  9. Vardhana
    Vardhana
  10. Batlevi
    Batlevi

Groups

  1. Center for Hematologic Malignancies (95)
  2. Department of Medicine (95)
  3. GSK Faculty (95)
  4. Hematologic Malignancies, Division of (95)
  5. Lymphoma (95)
  6. Human Oncology and Pathogenesis Program (61)
  7. Population Sciences Research Program (48)
  8. Survivorship Research (48)
  9. Hematologic Malignancies Research (43)
  10. Epidemiology and Biostatistics (41)
  1. "Center for Hematologic Malignancies"
  2. "Andrew Zelenetz"
  3. "GSK Faculty"
Formats
  1. Meeting Abstract (59)
  2. Journal Article (32)
  3. Book Section (2)
  4. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (95)
  2. Department of Medicine (95)
  3. GSK Faculty (95)
  4. Hematologic Malignancies, Division of (95)
  5. Lymphoma (95)
  6. Human Oncology and Pathogenesis Program (61)

More Groups

People
  1. Andrew Zelenetz (95)
  2. Maria Palomba (50)
  3. Ariela Noy (41)
  4. Anita Kumar (36)
  5. Andrew Intlekofer (35)
  6. Paul Hamlin (34)

More People

Years
  1. 2024 (2)
  2. 2023 (17)
  3. 2022 (8)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (3)

More Years

Publications
  1. Blood (46)
  2. Journal of Clinical Oncology (6)
  3. Hematological Oncology (4)
  4. Journal of Nuclear Medicine (3)
  5. Annals of Oncology (2)
  6. Blood Advances (2)

More Publications

Publishers
  1. American Society of Hematology (48)
  2. American Society of Clinical Oncology (6)
  3. Nature Publishing Group (6)
  4. Oxford University Press (4)
  5. Wiley Blackwell (4)
  6. American Association for Cancer Research (3)

More Publishers

Results (95)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma
    Research Letter

    Stuver, R.; Noy, A.; Vardhana, S. A.; Zelenetz, A. D.; Moskowitz, A. J.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127
    Journal Article

    Montoya, S.; Bourcier, J.; Noviski, M.; Lu, H.; Thompson, M. C.; Chirino, A.; Jahn, J.; Sondhi, A. K.; Gajewski, S.; Tan, Y. S.; more...
    Science (2024)

    Fulltext@MSK | Save
  • Genetic alterations of follicular lymphoma can predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Infectious complications in patients with relapsed or refractory (R/R) Non-Hodgkin's lymphoma (NHL) treated with the anti-CD20xCD3 bispecific antibody (BsAb) mosunetuzumab
    Meeting Abstract

    Shahid, Z.; Okwali, M.; Joseph, A.; Seo, S. K.; Lue, J. K.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma -Real world experience
    Meeting Abstract

    Luttwak, E.; Ganesan, N.; Boardman, A. P.; Caron, P.; David, K. A.; Rivas-Delgado, A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Potent CD8+T-cell proliferation and effector differentiation following subcutaneous (SC) mosunetuzumab administration in patients with untreated, high tumor-burden follicular lymphoma (FL)
    Meeting Abstract

    Falchi, L.; Lin, Y. H.; Melendez, L.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Kumar, A.; Palomba, M. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Subcutaneous (SC) mosunetuzumab (mosun) as first-line therapy for patients (pts) with high tumor-burden follicular lymphoma (FL): First results of a multicenter phase 2 study
    Meeting Abstract

    Falchi, L.; Okwali, M.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Palomba, M. L.; Kumar, A.; Torka, P.; more...
    Blood (2023)

    Fulltext@MSK | Save